Type of AML-M3 - Acute promyelocytic leukemia (APL) Posts on Medivizor
Navigation Menu

Type of AML-M3 – Acute promyelocytic leukemia (APL) Posts on Medivizor

Treating patients with high risk acute promyelocytic leukemia (APL) with ATRA, arsenic trioxide and gemtuzumab ozogamicin

Posted by on May 10, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated the effectiveness and safety of combing all-trans retinoic acid (ATRA; Vesanoid), arsenic trioxide (ATO; Trisenox), and gemtuzumab ozogamicin (GO; Milotarg) in treating patients with high risk (HR) acute promyelocytic leukemia (APL). The authors found that the combination therapy was effective and well...

Read More